Evidence map›Paper›PMID 26450656›Full record

ArticleExperimental eye research2016

Development of a novel in vivo corneal fibrosis model in the dog.

K M Gronkiewicz, E A Giuliano, K Kuroki, F Bunyak, A Sharma, L B C Teixeira, C W Hamm, R R Mohan

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Corneal stromal repair and regeneration.Progress in retinal and eye research · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. A rabbit model for evaluating ocular damage from acrolein toxicity in vivo.Annals of the New York Academy of Sciences · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

K M GronkiewiczDepartment of Veterinary Medicine and Surgery, College of Veterinary Medicine, Columbia, MO, USA; Harry S. Truman Memorial Veteran Hospital, Columbia, MO, USA.
E A GiulianoDepartment of Veterinary Medicine and Surgery, College of Veterinary Medicine, Columbia, MO, USA; Harry S. Truman Memorial Veteran Hospital, Columbia, MO, USA.
K KurokiDepartment of Veterinary Pathobiology, College of Veterinary Medicine, Columbia, MO, USA.
F BunyakDepartment of Computer Science, University of Missouri, Columbia, MO, USA.
A SharmaDepartment of Veterinary Medicine and Surgery, College of Veterinary Medicine, Columbia, MO, USA; Harry S. Truman Memorial Veteran Hospital, Columbia, MO, USA.
L B C TeixeiraDepartment of Pathological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, WI, USA.
C W HammMason Eye Institute, University of Missouri, Columbia, MO, USA.
R R MohanDepartment of Veterinary Medicine and Surgery, College of Veterinary Medicine, Columbia, MO, USA; Harry S. Truman Memorial Veteran Hospital, Columbia, MO, USA; Mason Eye Institute, University of Missouri, Columbia, MO, USA. Electronic address: mohanr@health.missouri.edu.
Missouri College · USCincinnati Eye Institute · USUniversity of Missouri · USUniversity of Wisconsin–Madison · US

Funding

Gene Therapy in the CorneaR01EY017294 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2007 to 2018
$4.3M
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal DiseasesI01BX000357 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI Rajiv Ravindra Mohan · 2009 to 2026
–
BLRD VA I01 BX000357NEI NIH HHS R01 EY017294NEI NIH HHS R01EY017294
6 · The paper itself

Abstract

The aim of this study was to develop a novel in vivo corneal model of fibrosis in dogs utilizing alkali burn and determine the ability of suberanilohydroxamic acid (SAHA) to inhibit corneal fibrosis using this large animal model. To accomplish this, we used seven research Beagle dogs. An axial corneal alkali burn in dogs was created using 1 N NaOH topically. Six dogs were randomly and equally assigned into 2 groups: A) vehicle (DMSO, 2 μL/mL); B) anti-fibrotic treatment (50 μM SAHA). The degree of corneal opacity, ocular health, and anti-fibrotic effects of SAHA were determined utilizing the Fantes grading scale, modified McDonald-Shadduck (mMS) scoring system, optical coherence tomography (OCT), corneal histopathology, immunohistochemistry (IHC), and transmission electron microscopy (TEM). The used alkali burn dose to produce corneal fibrosis was well tolerated as no significant difference in mMS scores between control and treatment groups (p = 0.89) were detected. The corneas of alkali burned dogs showed significantly greater levels of α-smooth muscle actin, the fibrotic marker, than the controls (p = 0.018). Total corneal thickness of all dogs post-burn was significantly greater than baseline OCT images irrespective of treatment (p = 0.004); TEM showed that alkali burned corneas had significantly greater minimum and maximum interfibrillar distances than the controls (p = 0.026, p = 0.018). The tested topical corneal alkali burn dose generated significant opacity and fibrosis in dog corneas without damaging the limbus as evidenced by histopathology, IHC, TEM, and OCT findings, and represents a viable large animal corneal fibrosis in vivo model. Additional in vivo SAHA dosing studies with larger sample size are warranted.

Indexed as

Disease Models, AnimalActinsAnimalsBiomarkersBurns, ChemicalCorneaCorneal DiseasesDogsEye BurnsFemaleFibrosisHistone Deacetylase InhibitorsHydroxamic AcidsImmunohistochemistrySodium HydroxideTomography, Optical CoherenceActinsBiomarkersHistone Deacetylase InhibitorsHydroxamic AcidsSodium HydroxideVorinostatAlkali burnCorneal fibrosisDogSuberanilohydroxamic acidα-smooth muscle actin

Identifiers

PMID26450656
PMCPMC4684711
OpenAlexW2212270069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.